Publisher： John Wiley & Sons Inc
E-ISSN： 1601-0825|21|3|283-291
ISSN： 1354-523x
Source： ORAL DISEASES, Vol.21, Iss.3, 2015-04, pp. : 283-291
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is There a Role for Chemosensitivity Tests in Head and Neck Cancer?
Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. :
Access to resources
Recommend
The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer
Oncology, Vol. 83, Iss. 2, 2012-07 ,pp. :
Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer
CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. :
The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer
Oncology, Vol. 93, Iss. 2, 2017-05 ,pp. :